AGP Executive Report
Last update: 2 hours agoHemp-THC Showdown: Federal restrictions due Dec. 11 could push many hemp-derived THC products off shelves and threaten small businesses. Bipartisan lawmakers are offering regulatory alternatives, while some GOP senators say they’ll oppose funding bills that keep the products legal. CBD Safety: A new clinical review surveys cannabidiol’s potential effects, drug interactions and manufacturing risks, as consumers increasingly turn to retail products without medical guidance. Product Claims: A proposed California class action alleges Camino’s THC sleep gummies don’t improve sleep and may make it worse; the claims have not been proven in court. Health Watch: A study of more than 415,000 U.S. adults found cannabis use disorder was associated with 57% higher odds of suicidal thoughts—an association, not proof of cause. Market Rules: Massachusetts regulators approved cannabis dispensary drive-throughs, while Texas lawmakers are weighing medical cannabis expansion and adult-use legalization proposals for 2027.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.